Eli Lilly
2,446 hedge funds and large institutions have $255B invested in Eli Lilly in 2022 Q2 according to their latest regulatory filings, with 211 funds opening new positions, 869 increasing their positions, 916 reducing their positions, and 81 closing their positions.
160% more first-time investments, than exits
New positions opened: 211 | Existing positions closed: 81
79% more funds holding in top 10
Funds holding in top 10: 102 → 183 (+81)
13% more capital invested
Capital invested by funds: $225B → $255B (+$29.6B)
4% more funds holding
Funds holding: 2,346 → 2,446 (+100)
4% more call options, than puts
Call options by funds: $1.87B | Put options by funds: $1.79B
0.09% more ownership
Funds ownership: 82.88% → 82.96% (+0.09%)
5% less repeat investments, than reductions
Existing positions increased: 869 | Existing positions reduced: 916
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$1.92B |
| 2 |
Morgan Stanley
New York
|
+$1.06B |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$875M |
| 4 |
Jennison Associates
New York
|
+$737M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$340M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$1.16B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.14B |
| 3 |
Lilly Endowment
Indiananapolis,
Indiana
|
-$598M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$471M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$442M |
LLY Hedge Fund Activity: Q2 2022 in Review
2,446 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2022, worth a combined $255B — up 13% from $225B a quarter earlier.
Buyers outnumbered sellers: 211 funds opened new LLY positions and 81 closed out — a net gain of 130 holders — while 869 added to existing stakes and 916 trimmed.
The largest buyer was Capital World Investors, adding an estimated $1.92B. The largest seller was Capital International Investors, cutting an estimated $1.16B.
- 2,446 institutional investors held Eli Lilly (LLY) as of Q2 2022, up from 2,346 in Q1 2022.
- Funds reported $255B of Eli Lilly stock for Q2 2022, up 13% quarter-over-quarter.
- 211 funds opened new Eli Lilly positions in Q2 2022 and 81 closed out, a net change of +130 holders.
- The largest Eli Lilly buyer in Q2 2022 was Capital World Investors, an estimated $1.92B added.
- The largest Eli Lilly seller in Q2 2022 was Capital International Investors, an estimated $1.16B sold.
Based on aggregated 13F filings for Q2 2022.